PharmAla Biotech Closes Purchase Order With Emyria Ltd., Completes Filing of “LaNeo” Trademark in Australia
February 14, 2023 08:00 ET
|
PharmAla Biotech
VANCOUVER, British Columbia, Feb. 14, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA) is pleased to announce that, in the wake of a landmark decision by the...
Dipharma completes second phase of CGMP expansion at its Kalamazoo site
February 10, 2023 10:29 ET
|
Dipharma Francis S.r.l
MILAN, Italy, Feb. 10, 2023 (GLOBE NEWSWIRE) -- Dipharma Francis S.r.l. (Dipharma), a global CDMO and leading manufacturer of Active Pharmaceutical Ingredients and advanced Intermediates, announced...
One Month Remains to Register for the cGMP Regulatory Inspections Course - Through the Eyes of FDA, EMA and PMDA (March 7, 2023)
February 06, 2023 05:43 ET
|
Research and Markets
Dublin, Feb. 06, 2023 (GLOBE NEWSWIRE) -- The "cGMP Regulatory Inspections - Through the Eyes of FDA, EMA and PMDA" training has been added to ResearchAndMarkets.com's offering. GMP-compliance is...
Australia Allows Prescription of MDMA and Psilocybin in Groundbreaking Regulatory Change
February 03, 2023 00:01 ET
|
PharmAla Biotech
VANCOUVER, British Columbia, Feb. 03, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA) applauds the Australian Therapeutic Goods Administration (TGA) in allowing for...
2 Day Online Course on Aseptic Processing in the Manufacture of Pharmaceutical and Biotech Products (February 2-3, 2023)
December 30, 2022 04:58 ET
|
Research and Markets
Dublin, Dec. 30, 2022 (GLOBE NEWSWIRE) -- The "2 Day Course on Aseptic Processing in the Manufacture of Pharmaceutical and Biotech Products 22" training has been added to ResearchAndMarkets.com's...
Raw Material Requirements (Health Canada/USP/EP) in a cGMP Environment: 2 Day Issues and Solutions Training Course (January 23-24, 2023)
December 30, 2022 04:38 ET
|
Research and Markets
Dublin, Dec. 30, 2022 (GLOBE NEWSWIRE) -- The "Raw Material Requirements (Health Canada/USP/EP) in a cGMP Environment - Issues and Solutions Training Course" training has been added to ...
Dipharma receives GMP certification from Brazilian ANVISA
December 01, 2022 08:46 ET
|
Dipharma Francis S.R.L
MILAN, Italy, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Dipharma Francis S.r.l. (Dipharma), a leading Contract Development and Manufacturing Organization (CDMO) and a global manufacturer of Active...
RespireRx Pharmaceuticals Inc. Announces Entry into Letter of Intent with Australian Headquartered CRO for Dronabinol Development for Obstructive Sleep Apnea
November 17, 2022 08:45 ET
|
RespireRX Pharmaceuticals Inc.
Glen Rock, N.J., Nov. 17, 2022 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC Pink Market:RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and...
Mindset Pharma and PharmAla Biotech Enter into Exclusive Sales Agreement
November 16, 2022 07:30 ET
|
PharmAla Biotech
VANCOUVER, British Columbia, Nov. 16, 2022 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA), a biotechnology company focused on the research, development, and manufacturing...
GMP Testing Service Global Market Report 2022: Continuous Proliferation of Pharmaceuticals Industry Drives Growth
November 07, 2022 08:58 ET
|
Research and Markets
Dublin, Nov. 07, 2022 (GLOBE NEWSWIRE) -- The "GMP Testing Service Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Service Type and End User" report has been added to ...